(Q73850106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Kariya Y

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kyogashima M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Suzuki K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Isomura T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sakamoto T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Horie K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ishihara M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Takano R

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kamei K

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hara S

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

25949-25958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Anticoagulantly active heparin-like molecules from vascular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Further characterization of the antithrombin-binding sequence in heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Fibroblast Growth Factor-2 Can Mediate Cell Attachment by Linking Receptors and Heparan Sulfate Proteoglycans on Neighboring Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

FGF-2 dimerization involvement in growth factor mediated cell proliferation but not cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

An Improved Method for the Preparation of Chondroitin by Solvolytic Desulfation of Chondroitin Sulfates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

N.m.r. spectroscopic observations related to the function of sulfate groups in heparin. Calcium binding vs. biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Novel regio- and stereoselective O-6-desulfation of the glucosamine moiety of heparin with N-methylpyrrolidinone-water or N,N-dimethylformamide-water mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

A novel regioselective desulfation of polysaccharide sulfates: Specific 6-O-desulfation with N,O-bis(trimethylsilyl)acetamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Disaccharide analysis of heparin and heparan sulfate using deaminative cleavage with nitrous acid and subsequent labeling with paranitrophenyl hydrazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

The disaccharide composition of heparins and heparan sulfates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Analysis of oligosaccharides from heparin by reversed-phase ion-pairing high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

A cell-based assay for evaluating the interaction of heparin-like molecules and basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Selection of COS cell mutants defective in the biosynthesis of heparan sulfate proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

Fibroblast growth factor receptors have different signaling and mitogenic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

An essential heparin-binding domain in the fibroblast growth factor receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M004140200

21 January 2018

Identifiers

DOI

10.1074/JBC.M004140200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837484%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference